- Achieve $35M of OTC portfolio through integrated strategic & tactical plans, indirect management of sales force & trade marketing teams and ongoing Sales/MS tracking
- Launch of TheraPearl® (www.Therapearl.com) in GCC to generate $5M, crafted full commercial plan with 5 years P&L for the region, from-scratch HCP & Consumer campaigns and over 900 POSM in big retailers such as Boots®
- PR & digital marketing plans preparation for TheraPearl to be active in 2017
- Re-branding of La Femme® -feminine hygiene category- in cooperation with R&D, QA and RA teams. Revamped outer & inner pack artwork, actual product & sample size plus 2 separate campaigns to HCP & DTC. Growth trend shows +37% vs LY in GNE.
- 2017 La Femme® launch in Egypt expanding feminine hygiene market.
- Assigned in collaboration with Valeant BDM to close the deal in exclusively commercializing Actipatch® (www.actipatch.com) in MENA region in 2017
- A&P budget & OPEX control for OTC portfolio and bi-annual NPV adjustment.
- Market research & consumer insights analysis to prepare investment plans with ROI
- Project lead in commercializing Generics portfolio in North Africa. Succeeded in closing $6M distribution deals in Kenya,Ughanda,Rwanda,Tanzania & Ethiopia
- Coaching marketing interns on basics of product, agency & vendor management
- Committee member of "ME Intern" program for hiring interns
- Life cycle management of Medpharma mature OTC/Generics portfolio ($9M) which includes Dandruff shampoo, baby cream, Antibiotic, and cough syrups.